TY - JOUR
T1 - Propentofylline improves learning and memory deficits in rats induced by β-amyloid protein-(1-40)
AU - Yamada, Kiyofumi
AU - Tanaka, Tomoko
AU - Senzaki, Kouji
AU - Kameyama, Tsutomu
AU - Nabeshima, Toshitaka
N1 - Funding Information:
We are grateful to Nippon Hoechst Marion Roussel for the supply of propentofylline. This study was supported, in part, by a Grant-in-Aid for Science Research from the Ministry of Education, Science, and Culture of Japan (No. 07557009 and 07557303), a grant from the Ministry of Health and Welfare's Foundation for Gerontological Science Research (91A-2406 and 94A-2405), and a grant from the Smoking Research Foundation.
PY - 1998/5/15
Y1 - 1998/5/15
N2 - We have reported that continuous infusion of β-amyloid protein-(1-40) into the cerebral ventricle produces learning and memory deficits in rats. Propentofylline has potent stimulatory effects on nerve growth factor (NGF) synthesis/secretion in mouse astrocytes in vitro and increases cerebral NGF content in aged rats. In the present study, we examined the effects of propentofylline on learning and memory deficits in β-amyloid protein- infused rats. The rats were given propentofylline orally once a day throughout the period of behavioral examination. In the β-amyloid protein- infused rats, spontaneous alternation behavior in a Y-maze, and performance in water maze and passive avoidance tasks were significantly impaired compared to sham-operated rats. Propentofylline prevented these behavioral deficits, but did not change the reduction of the activity of choline acetyltransferase in the hippocampus in the β-amyloid protein-infused rats. These results suggest that propentofylline is useful for the treatment of patients with Alzheimer's disease.
AB - We have reported that continuous infusion of β-amyloid protein-(1-40) into the cerebral ventricle produces learning and memory deficits in rats. Propentofylline has potent stimulatory effects on nerve growth factor (NGF) synthesis/secretion in mouse astrocytes in vitro and increases cerebral NGF content in aged rats. In the present study, we examined the effects of propentofylline on learning and memory deficits in β-amyloid protein- infused rats. The rats were given propentofylline orally once a day throughout the period of behavioral examination. In the β-amyloid protein- infused rats, spontaneous alternation behavior in a Y-maze, and performance in water maze and passive avoidance tasks were significantly impaired compared to sham-operated rats. Propentofylline prevented these behavioral deficits, but did not change the reduction of the activity of choline acetyltransferase in the hippocampus in the β-amyloid protein-infused rats. These results suggest that propentofylline is useful for the treatment of patients with Alzheimer's disease.
UR - http://www.scopus.com/inward/record.url?scp=0032524558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032524558&partnerID=8YFLogxK
U2 - 10.1016/S0014-2999(98)00166-6
DO - 10.1016/S0014-2999(98)00166-6
M3 - Article
C2 - 9669491
AN - SCOPUS:0032524558
SN - 0014-2999
VL - 349
SP - 15
EP - 22
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -